The 2024 Legislative Season Begins – Take Action on Two Important Bills This Week

by
Op-Ed

As the 2024 legislative season begins, I wanted to thank you all for your continued support and help furthering liberty in New Hampshire.

Most weeks, we ask that you sign in to support or oppose bills and write a brief email to the committee with your thoughts. The emails can be as simple as one or two sentences asking the committee to support or oppose the legislation or as long as you need to express your personal thoughts, but it makes a huge difference for the legislators to know that people are paying attention.

If you have time, all of these are public hearings. I have posted the building and room number if you wish to attend in person.

Key:
LOB= Legislative Office Building
SH= State House
HB= House Bill
SB= Senate Bill

 

Tuesday, January 9th, N.H. House
Commerce
LOB, Room 306-308

⭐ 10:30 a.m. – SUPPORT – HB 1232. This bill prohibits the government from using a central bank digital currency in any way. Central bank digital currency would mean a completely government controlled wealth system and needs to be fought in every possible.
🔗 Click here to register your disposition.
✉️ Email the committee.

 

Wednesday, January 10th, N.H. Senate
Health and Human Services
LOB, Room 101

⭐ 1:00 p.m. – SUPPORT – SB 319
This bill prohibits the state from purchasing, promoting, or distributing vaccines and pharmaceutical products without human clinical trials. The state of New Hampshire did purchase, promote and distribute the COVID booster before human trials and this precedent cannot be allowed to stand.
🔗 Click here to register your disposition.
✉️ Email
Regina.Birdsell@leg.state.nh.us
Kevin.Avard@leg.state.nh.us
Jeb.Bradley@leg.state.nh.us
Becky.Whitley@leg.state.nh.us
Suzanne.Prentiss@leg.state.nh.us

 

Author

  • Op-Ed

    GraniteGrok.com accepts Letters to the Editor, Op-Eds, Press releases, and other content. If you would like us to consider yours for publication, please email editor@granitegrok.com.  Submission does not guarantee publication.

Share to...